C12N 2760/18622
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2760/18622 (New viral proteins or individual genes, new structural or functional aspects of) appears on 108 US grants and 99 published applications in this corpus.
Search patents in C12N- Granted patents
- 108
- Published applications
- 99
- Assignees
- 71
- Inventors
- 191
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 5 | 0 |
| 2000 | 12 | 0 |
| 2001 | 12 | 0 |
| 2002 | 6 | 2 |
| 2003 | 2 | 8 |
| 2004 | 4 | 7 |
| 2005 | 2 | 5 |
| 2006 | 1 | 3 |
| 2007 | 4 | 6 |
| 2008 | 4 | 10 |
| 2009 | 6 | 3 |
| 2010 | 5 | 6 |
| 2011 | 1 | 4 |
| 2012 | 0 | 2 |
| 2013 | 0 | 2 |
| 2014 | 5 | 3 |
| 2015 | 2 | 3 |
| 2016 | 3 | 5 |
| 2017 | 7 | 2 |
| 2018 | 1 | 4 |
| 2019 | 4 | 2 |
| 2020 | 1 | 6 |
| 2021 | 4 | 1 |
| 2022 | 1 | 0 |
| 2023 | 1 | 1 |
| 2024 | 1 | 4 |
| 2025 | 2 | 4 |
| 2026 | 1 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/PIV3 F protein and uses thereof2 Jun 2026US 12,643,925 B2The U.S.A., as represented by the Secretary, Department of Health and Human Services
- Compositions and methods for stimulating natural killer cells7 Oct 2025US 12,435,121 B2University of Central Florida Research Foundation, Inc.
- Fusosome compositions and uses thereof5 Aug 2025US 12,378,578 B2Flagship Pioneering Innovations V, Inc.
- Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f protein and uses thereof25 Jun 2024US 12,018,051 B2The U.S.A., as represented by the Secretary, Department of Health and Human Services
- Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof28 Feb 2023US 11,591,372 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Prefusion-stabilized human parainfluenza virus 3 f proteins8 Oct 2026US 2026/0306613 A1Board of Regents, The University of Texas System
- Stabilized pre-fusion piv3 f proteins13 Aug 2026US 2026/0232789 A1Msd International Business GmbH
- Pre-fusion human piv1 f proteins21 May 2026US 2026/0139011 A1Janssen Vaccines & Prevention B. V.
- Anti-Viral Therapeutic Peptides, Conjugates, and Methods of Use Thereof14 May 2026US 2026/0131011 A1Decoy Therapeutics Inc.
- Stabilized trimeric class i fusion proteins26 Mar 2026US 2026/0085096 A1Janssen Vaccines & Prevention B. V.
Most cited
By later US patents
- Metapneumovirus strains and their use in vaccine formulations and sequences74US 8,722,341 B2MedImmune Vaccines, Inc. · 2014
- Viral glycoprotein subunit vaccine69US 4,790,987 AResearch Corporation · 1988
- Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine50US 5,869,036 ASt. Louis University · 1999
- Simian immunodeficiency virus peptides with antifusogenic and antiviral activities47US 6,017,536 ATrimeris, Inc. · 2000
- Production of viral antigens37US 4,517,304 ANational Research Development Corporation · 1985